Natera's Signatera wins Japan approval for colorectal cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TXN
3. NOW
4. TSLA
5. GOOG
6. IBM
7. KNX
8. CSX
9. LVS
10. INTC

Go back to Natera's Signatera wins Japan approval for colorectal cancer
(NASDAQ: NTRA) Delayed: 264.22 --0 (-0%)
Previous Close $264.22    52 Week High $13.80 
Open $264.22    52 Week Low $6.52 
Day High $264.22    P/E N/A 
Day Low $264.22    EPS $0.00 
Volume 2,023